Edition:
United Kingdom

Josephine Mason

AstraZeneca says COVID-19 'vaccine for the world' can be 90% effective

24 Nov 2020

LONDON AstraZeneca said on Monday its COVID-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective, giving the world's fight against the global pandemic a third new weapon that can be cheaper to make, easier to distribute and faster to scale-up than rivals. | Video

"Ein Impfstoff für die Welt" - AstraZeneca meldet Studienerfolg

23 Nov 2020

London/Frankfurt Auf der Suche nach einem Impfstoff gegen das Coronavirus hat mit AstraZeneca ein weiteres Pharmaunternehmen einen Studienerfolg erzielt.

"Ein Impfstoff für die Welt" - AstraZeneca meldet Studienerfolg

23 Nov 2020

London/Frankfurt Auf der Suche nach einem Impfstoff gegen das Coronavirus hat mit AstraZeneca ein weiteres Pharmaunternehmen einen Studienerfolg gemeldet.

Most people would get COVID-19 vaccine if offered by government or employer: poll

20 Oct 2020

LONDON Most people would get a COVID-19 vaccine if their government or employer recommended it, results of a global poll showed on Tuesday, amid growing concerns about public distrust of the shots being developed at speed to end the pandemic.

Oxford to study anti-inflammatory drug Humira as potential COVID-19 treatment

30 Sep 2020

LONDON Oxford University said on Wednesday it would study whether the world's best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients - the latest effort to repurpose existing drugs as potential coronavirus therapies.

Britain lines up more potential COVID-19 vaccine supplies with J&J, Novavax deals

14 Aug 2020

LONDON Britain will buy potential COVID-19 vaccines from U.S. drugmakers Johnson & Johnson and Novavax Inc , the companies said on Friday, boosting the number of deals it has with drugmakers as the global vaccine race rages on.

It's not for me: speed of COVID-19 vaccine race raises safety concerns

06 Aug 2020

BRUSSELS/LONDON The frenetic race to develop a COVID-19 vaccine has intensified safety concerns about an inoculation, prompting governments and drugmakers to raise awareness to ensure their efforts to beat the coronavirus aren't derailed by public distrust.

World News